By Wendy Diller
Published in the February 27, 2015 Issue (Vol. 2, No. 4)
The numbers for 2014 are now in for the major orthopedics manufacturers, and by most accounts, the knee and hip sectors are rebounding, albeit modestly. Overall growth appears to be in the low-single digits, led by Biomet Inc., Johnson & Johnson (J&J), and Zimmer Inc. in knee implants and J&J and Biomet in hip implants. While the performance is hardly a triumph according to the standards of most R&D-driven sectors of life sciences, after five discouraging years plagued by pricing headwinds and soft procedure demand, even 2% or 3% seems upbeat.
The stage appears set for a modest rebound in the hip and knee replacement markets, although pricing pressures remain.